Integrative decisions in rectal cancer

Annals of Oncology

Volumn 18, Issue SUPPL. 9, 2007, Pages

  Cervantes, A ^a   Rodriguez Braun E ^a   Navarro, S ^a   Hernandez A ^a   Campos, S ^a   Garcia Granero E ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL DECISION MAKING; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DIGITAL RECTAL EXAMINATION; DISEASE FREE SURVIVAL; ECHOGRAPHY; EVIDENCE BASED MEDICINE; HUMAN; INTEGRATIVE MEDICINE; INTERDISCIPLINARY COMMUNICATION; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; OVERALL SURVIVAL; PATIENT SELECTION; PRACTICE GUIDELINE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; PROGNOSIS; RECTUM CANCER; RECTUM SURGERY; RECURRENCE RISK; TOTAL QUALITY MANAGEMENT; PATHOLOGY; PATIENT REFERRAL; PUBLIC RELATIONS; RADIOGRAPHY; RECTUM TUMOR; REVIEW; TREATMENT OUTCOME;

HUMANS; INTERDISCIPLINARY COMMUNICATION; INTERPROFESSIONAL RELATIONS; NEOPLASM STAGING; PROGNOSIS; RECTAL NEOPLASMS; REFERRAL AND CONSULTATION; TREATMENT OUTCOME;

EID: 36049028356     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdm307     Document Type: Conference Paper

References (26)

1. NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 1990; 264: 1444-1450.
2. Marding A, Holm T, Rutqvist LE et al. Impact of a surgical training program on rectal cancer outcomes in Stockholm. Br J Surg 2005; 92: 225-229.
3. Mercury Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. Br Med J 2006; 333: 779-785.
4. Quirke P. Training and quality assurance for rectal cancer: 20 years of data is enough. Lancet Oncol 2003; 4: 695-702.
5. Kapiteijn E, Marijnen CA, Nagtegaal ID et al. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med 2001; 345: 638-646.
6. Sauer R, Becker H, Hohenberger W et al. Preoperative versus postoperative Chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740.
7. Bosset JF, Collette L, Calais G et al. Chemotherapy with Preoperative Radiotherapy in Rectal Cancer. N Eng J Med 2006; 355: 1114-1123.
8. Chau I, Brown G, Cunningham D et al. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor risk rectal cancer. J Clin Oncol 2006; 24: 668-674.
9. Birbeck KF, Macklin CP, Tiffin NJ et al. Rates of circumferential margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 2002; 235: 449-457.
10. Nagtegaal ID, Marijnen CA, Kranenbarg EK et al. Circumferential margin involvement is still an important predictor of local recurrence in rectal carcinoma: Not one millimeter but two millimeters is the limit. Am J Surg Pathol 2002; 26: 350-357.
11. Wibe A, Rendedal PR, Svensson E et al. Prognostic significance of the circumferential resection margin following total mesorectal excision for rectal cancer. Br J Surg 2002; 89: 327-334.
12. Mawdsley S, Glynne-Jones R, Grainger J et al. Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival? Int J Radiat Oncol Biol Phys 2005; 63: 745-752.
13. Burton S, Brown G, Daniels IR et al. MRI directed multidisciplinary team preoperative treatment strategy: The way to eliminate positive circumferential margins? Br J Cancer 2006; 94: 351-357.
14. Finlay I. Preoperative staging for rectal cancer. Br Med J 2006; 333: 766-767.
15. Beets-Tan RG, Beets GL. Rectal cancer: Review with emphasis on MR imaging. Radiology 2004; 232: 335-346.
16. Brown G, Radcliffe AG, Newcombe RG et al. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 2003; 90: 355-364.
17. Burton S, Brown G, Daniels IR et al. MRI identified prognostic features of tumours in distal sigmoid, rectosigmoid and upper rectum: Treatment with radiotherapy and chemotherapy. Int J Radiation Oncol Biol Phys 2006; 65: 445-451.
18. Cervantes A, Chirivella I, Rodriguez-Braun E et al. A multimodality approach to localized rectal cancer. Ann Oncol 2006; 17 (Suppl 10): 127-134.
19. Departrnent of Health, UK. Topic 2B. Colorectal multidisciplinary team In: Manual for Cancer Services, 2004.
20. National Institute for Clinical Excellence. Improving outcomes in colorectal cancer 2004 http://www.nice.org.uk/page.aspx?o=204541.
21. Madoff RG. Chemoradiotherapy for rectal cancer - When, Why and How? N Eng J Med 2004; 351: 1790-1792.
22. Fleissig A, Jenkins V, Catt S et al. Multidisciplinary teams in cancer care: Are they effective in the UK? Lancet Oncol 2006; 7: 935-943.
23. Blazeby JM, Wilson L, Metcalfe C et al. Analysis of clinical decision-making in multi-disciplinary cancer teams. Ann Oncol 2006; 17: 457-460.
24. Glynne-Jones R, Mawdsley S, Pearce T et al. Alternative clinical end points in rectal cancer - are we getting closer? Ann Oncol 2006; 17: 1239-1248.
25. Sebag-Montefiore D, Steele R, Quirke P et al. Routine short course pre-op radiotherapy or selective post-op chemoradiotherapy for resectable rectal cancer? Preliminary results of the MRC CR07 randomised trial. J Clin Oncol 2006 ASCO Meeting Abstracts 3511.
26. Quirke P, Sebag-Montefiore D, Steele R et al. Local recurrence after rectal cancer resection is strongly related to the plane of surgical dissection and is further reduced by pre-operative short course radiotherapy. Preliminary results of the Medical Research Council (MRC) CR07 trial. J Clin Oncol 2006 ASCO Meeting Abstracts 3512.